Hospital Clínic de Barcelona | IDIBAPS
Pioneering Translational Research in IBD
Combining cutting-edge technologies with clinical excellence to improve the lives of patients with Crohn's Disease and Ulcerative Colitis.
Combining cutting-edge technologies with clinical excellence to improve the lives of patients with Crohn's Disease and Ulcerative Colitis.
The IBD Unit is a world-class reference center, accredited as excellent (2017, 2021, 2024) by GETECCU. We provide comprehensive multidisciplinary care for over 2,500 patients annually.
Our multidisciplinary team integrates Gastroenterology, Surgery, Radiology, and Pathology to ensure tailored outcomes for every individual, including specialized programs for pregnancy and pediatric transitions.
We host residents and physicians globally (Argentina, Italy, Chile, and more) for advanced training in IBD management and translational medicine.
Unraveling disease mechanisms through state-of-the-art technologies.
Dissecting the cellular heterogeneity of the intestinal mucosa to identify unique patient subpopulations and therapeutic responders.
Mapping gene expression within the tissue architecture to understand how cells interact in microenvironments like granulomas and ulcers.
Utilizing epithelial stem cell cultures to study barrier dysregulation and test alternative therapeutic targets in a personalized model.
Spatial resolution of macrophage and neutrophil heterogeneity in human IBD.
Read Overview →Identifying mechanisms of resistance to Tofacitinib through myeloid hyperactivation.
Read Overview →TL1A-activated T cells and their role in remodeling the rectal mucosa.
Read Overview →